LANKLER DOUGLAS M
SEC CIK 1488270 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| PFE | Pfizer | EVP | 280.0K | — | $4.07M | 17 | 2021-11-26 | 2026-02-25 |
Most active insiders at PFE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | BOURLA ALBERT | COB, CEO, Dir | $1.00M | — |
| 2 | BLAYLOCK RONALD E | Dir | $998.8K | — |
| 3 | Buckley Mortimer J | Dir | $960.4K | — |
| 4 | DAMICO JENNIFER B. | SVP, Ctrl | — | $134.7K |
| 5 | BOSHOFF CHRISTOFFEL | Pres, R, D | — | — |
| 6 | McDermott Michael | EVP | — | — |
| 7 | SAHNI PAYAL | EVP | — | — |
| 8 | LANKLER DOUGLAS M | EVP | — | — |
| 9 | Fonseca Lidia | EVP | — | — |
Transactions 17
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-02-27 | 2026-02-25 | PFE | Pfizer | LANKLER DOUGLAS M | EVP | F - Tax | $26.92 | -119.0K | 280.0K | -30% | -$3.20M |
| D | 2026-02-27 | 2026-02-25 | PFE | Pfizer | LANKLER DOUGLAS M | EVP | M - OptEx | $33.82 | +122.9K | 282.2K | +77% | +$4.16M |
| D | 2025-03-03 | 2025-02-27 | PFE | Pfizer | LANKLER DOUGLAS M | EVP | M - OptEx | $31.31 | +156.9K | 309.8K | +103% | +$4.91M |
| DM | 2025-03-03 | 2025-02-27 | PFE | Pfizer | LANKLER DOUGLAS M | EVP | F - Tax | $26.06 | -150.6K | 306.2K | -33% | -$3.92M |
| DM | 2025-02-25 | 2025-02-22 | PFE | Pfizer | LANKLER DOUGLAS M | EVP | F - Tax | $26.09 | -79.9K | 229.4K | -26% | -$2.08M |
| D | 2025-02-25 | 2025-02-22 | PFE | Pfizer | LANKLER DOUGLAS M | EVP | M - OptEx | $30.17 | +85.8K | 232.8K | +58% | +$2.59M |
| DM | 2024-02-27 | 2024-02-23 | PFE | Pfizer | LANKLER DOUGLAS M | EVP | F - Tax | $27.40 | -84.0K | 146.9K | -36% | -$2.30M |
| D | 2024-02-27 | 2024-02-23 | PFE | Pfizer | LANKLER DOUGLAS M | EVP | M - OptEx | $27.34 | +95.8K | 230.9K | +71% | +$2.62M |
| 2023-02-28 | 2023-02-25 | PFE | Pfizer | LANKLER DOUGLAS M | EVP | F - Tax | $41.75 | -26.4K | 135.1K | -16% | -$1.10M | |
| D | 2023-02-24 | 2023-02-22 | PFE | Pfizer | LANKLER DOUGLAS M | EVP | F - Tax | $42.38 | -19.9K | 161.5K | -11% | -$842.4K |
| DM | 2022-12-16 | 2022-12-14 | PFE | Pfizer | LANKLER DOUGLAS M | EVP | M - OptEx | $26.29 | +101.7K | 180.5K | +129% | +$2.67M |
| 2022-05-13 | 2022-05-12 | PFE | Pfizer | LANKLER DOUGLAS M | EVP | S - Sale | $49.41 | -38.3K | 78.8K | -33% | -$1.89M | |
| D | 2022-03-01 | 2022-02-26 | PFE | Pfizer | LANKLER DOUGLAS M | EVP | M - OptEx | $25.60 | +77.7K | 174.5K | +80% | +$1.99M |
| DM | 2022-03-01 | 2022-02-26 | PFE | Pfizer | LANKLER DOUGLAS M | EVP | F - Tax | $49.56 | -57.4K | 117.1K | -33% | -$2.85M |
| D | 2022-02-25 | 2022-02-23 | PFE | Pfizer | LANKLER DOUGLAS M | EVP | M - OptEx | $27.34 | +115.3K | 181.7K | +174% | +$3.15M |
| DM | 2022-02-25 | 2022-02-23 | PFE | Pfizer | LANKLER DOUGLAS M | EVP | F - Tax | $49.84 | -84.9K | 96.8K | -47% | -$4.23M |
| M | 2021-11-30 | 2021-11-26 | PFE | Pfizer | LANKLER DOUGLAS M | EVP | S - Sale | $54.37 | -40.0K | 104.2K | -28% | -$2.17M |
Purchase Sale Sale after option exercise All abbreviations